Advanced prostate cancer is cancer that has spread beyond the prostate to distant parts of the body. It is also called ...

Prostate cancer stands as one of the most prevalent cancers affecting men worldwide. Each year, millions of men and their ...

Sir Chris Hoy revealed the news he has just two to four years left to live - but he still remains hopeful new treatments ...

Sir Chris Hoy has spoken about the year since being diagnosed with terminal cancer and how he is responding to treatment ...

Advanced imaging reveals hidden metastases in high-risk prostate cancer cases, offering new insights for better diagnosis and treatment strategies.

Recently, licensed and emerging treatments for metastatic castrate-resistant prostate cancer are transforming the prognosis for men whose disease has already progressed during or after docetaxel ...

The results were promising. Men on the omega-3-rich diet experienced a 15% decrease in the Ki-67 index, while the control ...

Study finds uneven access to prostate cancer clinical trials. While Black men's enrollment was similar to White men, Hispanic ...

Discover a study that shows that despite promising data, metformin does not appear to impact disease progression in men with low-risk prostate cancer.

Discover the study supports the potential of neoadjuvant androgen deprivation therapy as an adjunctive therapy in HRLPC.